ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1815

Dynamic Changes in Microbiota Representation of a Gut Pathobiont and Clinical Disease Activity in Patients with Lupus Nephritis

Doua Azzouz1, Ze Chen2, Zhi Li3, Peter Izmirly4, Jing Deng1, David Fenyo3, Jill Buyon1, Alexander Alekseyenko5 and Gregg Silverman6, 1Department of Medicine, NYU School of Medicine, New York, NY, 2Department of Microbiology, NYU School of Medicine, New York, NY, 3Institute for Systems Genetics, NYU School of Medicine, New York, NY, 4Department of Medicine, New York University School of Medicine, New York, NY, 5Medical University of South Carolina, Charleston, SC, 6Laboratory of B cell immunobiology, Department of Medicine, NYU School of Medicine, New York, NY

Meeting: ACR Convergence 2020

Keywords: genomics, longitudinal studies, Lupus nephritis, microbiome, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: From a cross-sectional cohort, we have recently identified a candidate human gut pathobiont, Ruminococcus gnavus (RG) of the Lachnospiraceae family and Blautia genus that was linked to active Lupus nephritis (LN)(1). LN patients often displayed gut blooms of RG, concordant with serum IgG anti-RG antibody responses that appeared intertwined with anti-dsDNA responses implicated in renal pathogenesis. The dynamics of RG representation within SLE microbiota ecosystems have not been investigated. The genomic sequences of few RG strains have been reported, and these vary greatly in genome structure, gene representation and sequence.

Methods: A total of 53 fecal samples from 16 SLE patients and 63 samples from 11 CTL, at 2-12 time-points were studied, and patients were characterized for demographics, and clinical disease activity. High-throughput 16S rRNA amplicon libraries from fecal samples were analyzed using QIIME 2 and DADA2 (1). Hundreds of individual fecal RG colonies from two active LN patients were isolated and subjected to whole genome sequencing (WGS), with phylogenetic assignments in part based on inter-strain average nucleotide identity, multi-locus sequence typing and reference-guided genomic assemblies.

Results: Our analysis confirmed highly conserved patterns of gut community representation in SLE patients that displayed reduced microbiota richness, which was most pronounced in patients with high SLEDAI (p= 0.0023) and LN (p=0.002), confirming earlier reported findings [1]. Beta diversity analysis showed significant heterogeneity in SLE microbiome compared to CTL (p= 0.001). Similarly, RG abundance was greater in patients with high SLEDAI (p= 0.0021) and LN compared to CTL (p= 0.003). Tracking of the dynamic representation of RG at different time points within individual subjects, in CTL and many Lupus patients showed little or no detectable perturbations. Strikingly, in LN patients examined, there was a direct correlation between representation of RG and the SLEDAI score of overall disease activity in 53% of LN patients overtime. WGS analysis of the RG isolated colonies discovered four distinct RG strains with large genomic variations, which differ from previously reported RG  strains from other diseases and healthy donors.

Conclusion: Our findings suggest that intestinal blooms of the RG candidate pathobiont correlate with serious increases in Lupus disease activity, and especially LN. In pilot studies we have isolated and characterized the genomes of the first RG strains from active SLE patients. Our findings suggest that both dynamic representation and colonization by specific RG strains identified by their genomic composition, may have implications for the host-pathobiont relationship and the immune activation that is integral to Lupus pathogenesis.


Disclosure: D. Azzouz, None; Z. Chen, None; Z. Li, None; P. Izmirly, GSK, 5; J. Deng, None; D. Fenyo, None; J. Buyon, None; A. Alekseyenko, None; G. Silverman, None.

To cite this abstract in AMA style:

Azzouz D, Chen Z, Li Z, Izmirly P, Deng J, Fenyo D, Buyon J, Alekseyenko A, Silverman G. Dynamic Changes in Microbiota Representation of a Gut Pathobiont and Clinical Disease Activity in Patients with Lupus Nephritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/dynamic-changes-in-microbiota-representation-of-a-gut-pathobiont-and-clinical-disease-activity-in-patients-with-lupus-nephritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dynamic-changes-in-microbiota-representation-of-a-gut-pathobiont-and-clinical-disease-activity-in-patients-with-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology